Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01968005 · ClinicalTrials.gov registry record · Phase 3
Etodolac-Lidocaine Patch in the Treatment of Acute Low Back Pain
A Phase 3 study, sponsored by MEDRx USA.
- Completed
- Registry status
- Phase 3
- Development phase
- 232
- Enrollment target
NCT01968005 is a Phase 3 study that has completed, run by MEDRx USA. The registered enrollment target is 232 participants.
The verdict
NCT01968005, a Phase 3 study, has completed, sponsored by MEDRx USA.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 232 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate efficacy, tolerability and safety of Etoreat®(Etodolac-Lidocaine Topical Patch) in the treatment of acute low back pain (LBP).
Interventions
- DRUG Placebo
- DRUG Etoreat®(Etodolac-Lidocaine Topical Patch)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01968005
The ClinicalTrials.gov registry entry for NCT01968005 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 232 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MEDRx USA, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01968005 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01968005 about?
NCT01968005 is a clinical study titled "Etodolac-Lidocaine Patch in the Treatment of Acute Low Back Pain". The purpose of this study is to evaluate efficacy, tolerability and safety of Etoreat®(Etodolac-Lidocaine Topical Patch) in the treatment of acute low back pain (LBP).
What is the current status of trial NCT01968005?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 232 participants. The study started on 2013-11. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01968005?
The interventions under investigation include: Placebo (DRUG), Etoreat®(Etodolac-Lidocaine Topical Patch) (DRUG).
Who is sponsoring clinical trial NCT01968005?
This trial is sponsored by MEDRx USA, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.